ロード中...

Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma

BACKGROUND: Previous studies have explored cancer immunotherapy with radiotherapy or anti-angiogenic therapy, but no trials have reported a triple therapy approach. This study aimed to investigate safety and clinical outcome of PD-1/PD-L1 inhibitors combined with palliative radiotherapy and targeted...

詳細記述

保存先:
書誌詳細
出版年:Front Oncol
主要な著者: Zhong, Liting, Wu, Dehua, Peng, Weiwei, Sheng, Hailong, Xiao, Yazhi, Zhang, Xuebing, Wang, Yuli
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8170410/
https://ncbi.nlm.nih.gov/pubmed/34094988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.686621
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!